PATENTS

Xana™ has applied for several patents to protect the results of its research and development worldwide.

AURICULAR NEUROSTIMULATION DEVICE AND SYSTEM

This invention relates to an auricular neurostimulation device wearable by a user and configured to stimulate the Auricular Branch of Vagus Nerve (ABVN) on the user’s ear.

The device comprises at least two electrodes designed to be located in the cymba and in the cavity of the cavum conchae respectively. The electrodes stimulate the nerve ramifications of the cymba and the cavum conchae, respectively, when an electrical voltage difference is applied between them.

The invention further refers to an auricular neurostimulation system comprising an auricular neurostimulation device as described and a charging case where the device can charge an internal battery and where the device discharges into this case the data captured by the photoplethysmographic or biosensor during stimulation and sends them to a dedicated platform in the cloud. 

EUROPEAN PATENT GRANTED

This invention has been approved in Spain, Portugal, France, Italy, Germany, United Kingdom, Switzerland, Belgium, Netherlands, Denmark, Austria, Poland, Finland, Norway, Sweden, Ireland, Liechtenstein , Luxembourg and San Marino.

WORLDWIDE 

Pending national phase approval in United States, China, India, Japan, Canada, South Korea and Australia.